Article
Development of stage-dependent glycans on the Fc domains of IgG antibodies of ALS animals.
Experimental neurology - 1 May 2015
Edri-Brami Meital, Sharoni Hila, Hayoun Dana, Skutelsky Linor, Nemirovsky Ana, Porgador Angel, Lichtenstein Rachel G
Abstract excerpt
We recently revealed a unique glycan on the Fc domain of IgG antibodies in ALS patients that mediates antibody-dependent cell cytotoxicity (ADCC). This glycan has a bi-antennary structure that lacks the core fucose and sialic acid residues but contains a bisecting GlcNAc (A2BG2). Little is known, however, about the incidence of A2BG2 expression and IgG cytotoxicity under ALS conditions within well-defined...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
